Skip to main content

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in EW — Edwards Lifesciences Corp

CIK 1632972 PLYMOUTH, MN

Position in EW

as of Mar 31, 2026 · filed Apr 8, 2026
Position Value
$7,114,307
-$1,055,115 QoQ
Shares Held
88,840
-7.3% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2021
17 quarters on record
Voting authority Sole 4.904322377307519.ToString("F0")% Shared 0.ToString("F0")% None 95.09567762269248.ToString("F0")%

Common Shares in EW Over Time

Shares Held

Position Value (USD)

Derivatives in EW

reported options exposure · as of Sep 30, 2024
CallValue
$0
CallShares
0
PutValue
$626,905
PutShares
9,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $292,456,726 across 40 Medical Devices names. EW ranks #5 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 EW
Edwards Lifesciences Corp
This page
88,840 $7,114,307

All Filings in EW

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $7,114,307 88,840
2025-12-31 $8,169,422 95,829
2025-09-30 $7,353,853 94,559
2025-06-30 $12,764,028 163,202
2025-03-31 $5,582,119 77,016
2024-12-31 $5,724,591 77,328
2024-09-30 $626,905 9,500
2024-09-30 $5,285,403 80,094
2024-06-30 $7,623,388 82,531
2024-06-30 $877,515 9,500
2024-03-31 $8,188,727 85,692
2024-03-31 $907,820 9,500
2023-12-31 $6,091,612 79,890
2023-09-30 $5,454,414 78,730
2023-06-30 $654,272 6,936
2023-03-31 $473,960 5,729
2022-09-30 $1,183,261 14,320
2022-03-31 $6,250,107 53,093
2021-12-31 $6,487,475 50,077
2021-09-30 $7,831,528 69,177